Genolution Inc. (225220) - Total Liabilities

Latest as of September 2025: ₩26.44 Billion KRW ≈ $17.92 Million USD

Based on the latest financial reports, Genolution Inc. (225220) has total liabilities worth ₩26.44 Billion KRW (≈ $17.92 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Genolution Inc. (225220) equity growth momentum to track the company's year-over-year net asset growth rate.

Genolution Inc. - Total Liabilities Trend (2016–2024)

This chart illustrates how Genolution Inc.'s total liabilities have evolved over time, based on quarterly financial data. See Genolution Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Genolution Inc. Competitors by Total Liabilities

The table below lists competitors of Genolution Inc. ranked by their total liabilities.

Company	Country	Total Liabilities
PRI EKOPARK SA ZY -10 F:NPA	Germany	€18.98 Million
Edaran Bhd KLSE:5036	Malaysia	RM129.54 Million
Telefield Inc KQ:091440	Korea	₩84.75 Billion
Khind Holdings Bhd KLSE:7062	Malaysia	RM126.37 Million
Hanchang KO:005110	Korea	₩85.91 Billion
FINEDIGITAL Inc KQ:038950	Korea	₩11.17 Billion
Visionary Gold Corp V:VIZ	Canada	CA$847.41K
Berkosan Yalitim ve Tecrit Maddeleri Uretim ve Ticaret AS IS:BRKSN	Turkey	TL227.16 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Genolution Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 225220 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	5.48	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.36	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Genolution Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Genolution Inc. (2016–2024)

The table below shows the annual total liabilities of Genolution Inc. from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩26.16 Billion ≈ $17.73 Million	+0.68%
2023-12-31	₩25.99 Billion ≈ $17.61 Million	+31.55%
2022-12-31	₩19.75 Billion ≈ $13.39 Million	+55.08%
2021-12-31	₩12.74 Billion ≈ $8.63 Million	-43.34%
2020-12-31	₩22.48 Billion ≈ $15.24 Million	+108.37%
2019-12-31	₩10.79 Billion ≈ $7.31 Million	+32.26%
2018-12-31	₩8.16 Billion ≈ $5.53 Million	+1058.74%
2017-12-31	₩704.01 Million ≈ $477.10K	+23.38%
2016-12-31	₩570.62 Million ≈ $386.70K	--

About Genolution Inc.

KQ:225220 Korea Biotechnology

Market Cap

$15.82 Million

₩23.34 Billion KRW

Market Cap Rank

#25788 Global

#1919 in Korea

Share Price

₩1292.00

Change (1 day)

-0.31%

52-Week Range

₩1030.00 - ₩2590.00

All Time High

₩10300.23